An increasing number of European countries have detected gonococcal strains resistant to the antibiotic ceftriaxone, the first-line drug to treat gonorrhoea infection. Alongside growing evidence of the domestic spread of such resistant strains in Europe over the last two years, this poses a significant challenge for future treatment options for one of the most common sexually transmitted diseases worldwide, according to an assessment issued by the European Centre for Disease Prevention and Control (ECDC) today…
Source: European Centre for Disease Prevention and Control (ECDC)
European Centre for Disease Prevention and Control (ECDC)
- Drug-resistant gonorrhoea on the rise in Europe, ECDC warns
- Amidst heatwave across Europe, ECDC launches improved tool for monitoring the risk of infection in coastal waters
- Ebola disease outbreak in the Democratic Republic of the Congo and Uganda
- Enjoying the summer safely: health risks to keep in mind
- Multi-country outbreak of Salmonella Stanley infections linked to flavoured noodle products
- Multi-country Salmonella outbreak linked to alfalfa sprouted seeds
- Registrations now open for online attendance of ESCAIDE 2026, Europe’s leading public health conference
- As first imported Ebola case is recorded in Europe, ECDC calls on EU Member States to continue investing in preparedness
- Safer blood, tissues, and cells: ECDC defines unified hepatitis B and C virus screening guidelines for European donations
- Strengthening Europe’s preparedness against mosquito-borne diseases
